-
Study aim
-
Investigating the association between clinical and ocular characteristics with the outcomes of corneal collagen cross-linking (CXL) in patients with keratoconus (KC)
-
Design
-
Clinical trial without control group and only
-
Settings and conduct
-
This study was a prospective cohort study that enrolls all possible cases (85 eyes) of surgical naive KC who were candidate for CXL, were visited in Feiz Eye Hospital affiliated to Isfahan University of medical sciences, Isfahan, Iran.
At the surgical day, demographic information including sex, age and smoking, and familial history of kc, clinical diagnosis including visual acuity, intraocular pressure, biomicroscope slit lamp, ophthalmoscopy indiameter, pentacon imaging and laboratory tests including surface markers for tear biomarkers were collected. Patients were visited from one day and three days after surgery for possible complications including corneal opacity, refractive back disorder.The next day, three days, 90 days and one year after the intervention, clinical and laboratory cases and possible complications were evaluated and recorded.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:
keratoconus patients who are newly candidates for corneal collagen cross-linking.
Patient satisfaction.
Non-Inclusion criteria:
other corneal diseases.
pregnancy, and breastfeeding period.
Patients who have any of the following concomitant ocular diseases: diabetic macular edema, age-related macular degeneration.
-
Intervention groups
-
A total of 85 patients with keratoconus were evaluated for visual acuity, intraocular pressure, and tear biomarkers prior to surgery for collagen cornea linkages. Three days later, 90 days later and one year later, these cases were measured and recorded.
-
Main outcome variables
-
Visual acuity, intraocular pressure, surface of tear biomarkers